India's Serum Institute 'to invest in UK'
- The Serum Institute of India (SII) is the world's largest vaccine maker by volume, and has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot.
LONDON: Vaccine maker the Serum Institute of India is set to invest in facilities in Britain and could even manufacture inoculations in the UK in future, Prime Minister Boris Johnson said Monday.
Johnson's Downing Street office said the £240 million ($334 million) project would include a sales office, "clinical trials, research and development and possibly manufacturing of vaccines".
The Serum Institute of India (SII) is the world's largest vaccine maker by volume, and has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot.
SII has also begun phase one trials in the UK of a one-dose nasal vaccine for coronavirus.
Downing Street said the vaccine maker's plans were part of a wider package of trade and investment deals with India worth £1 billion that it expects to create over 6,500 jobs.
It was announced ahead of virtual talks between Johnson and Indian Prime Minister Narendra Modi on Tuesday.
Comments
Comments are closed for this article.